122 related articles for article (PubMed ID: 9522038)
1. Investigation on the effect of experimental phospholipase A2 inhibitors on the formyl-methionyl-leucyl-phenylalanine-stimulated chemotaxis of human leukocytes in vitro.
Hinder M
Arzneimittelforschung; 1998 Jan; 48(1):77-81. PubMed ID: 9522038
[TBL] [Abstract][Full Text] [Related]
2. Phospholipase A2 is involved in chemotaxis of human leukocytes.
Tibes U; Hinder M; Scheuer W; Friebe WG; Schramm S; Kaiser B
Adv Exp Med Biol; 1999; 469():189-97. PubMed ID: 10667330
[No Abstract] [Full Text] [Related]
3. Mechanisms of the priming effect of lipopolysaccharides on the biosynthesis of leukotriene B4 in chemotactic peptide-stimulated human neutrophils.
Surette ME; Dallaire N; Jean N; Picard S; Borgeat P
FASEB J; 1998 Nov; 12(14):1521-31. PubMed ID: 9806761
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of human neutrophil chemotaxis by the protein kinase inhibitor, 1-(5-isoquinolinesulfonyl) piperazine.
Harvath L; McCall CE; Bass DA; McPhail LC
J Immunol; 1987 Nov; 139(9):3055-61. PubMed ID: 2822802
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of the production of platelet activating factor and of leukotriene B4 in activated neutrophils by nimesulide due to an elevation of intracellular cyclic adenosine monophosphate.
Tool AT; Verhoeven AJ
Arzneimittelforschung; 1995 Oct; 45(10):1110-4. PubMed ID: 8595070
[TBL] [Abstract][Full Text] [Related]
6. Inhibitors of nitric oxide synthase attenuate human neutrophil chemotaxis in vitro.
Belenky SN; Robbins RA; Rennard SI; Gossman GL; Nelson KJ; Rubinstein I
J Lab Clin Med; 1993 Oct; 122(4):388-94. PubMed ID: 7693839
[TBL] [Abstract][Full Text] [Related]
7. Effects of pancreatic and snake venom phospholipase A2 on the generation of leukotriene B4 and C4 by human leukocytes in vitro.
Shimizu T; Hansson GC; Strandvik B
Pancreas; 1994 Jan; 9(1):37-41. PubMed ID: 8108369
[TBL] [Abstract][Full Text] [Related]
8. Various authentic chemoattractants mediating leukocyte adherence inhibition.
Thomson DM
J Natl Cancer Inst; 1984 Sep; 73(3):595-605. PubMed ID: 6088878
[TBL] [Abstract][Full Text] [Related]
9. Anethole and eugenol reduce in vitro and in vivo leukocyte migration induced by fMLP, LTB4, and carrageenan.
Estevão-Silva CF; Kummer R; Fachini-Queiroz FC; Grespan R; Nogueira de Melo GA; Baroni S; Cuman RK; Bersani-Amado CA
J Nat Med; 2014 Jul; 68(3):567-75. PubMed ID: 24789168
[TBL] [Abstract][Full Text] [Related]
10. Selective inhibition of human neutrophil chemotaxis to N-formyl-methionyl-leucyl-phenylalanine by sulfones.
Harvath L; Yancey KB; Katz SI
J Immunol; 1986 Aug; 137(4):1305-11. PubMed ID: 3016092
[TBL] [Abstract][Full Text] [Related]
11. Modulation of the heterogeneous membrane potential response of neutrophils to N-formyl-methionyl-leucyl-phenylalanine (FMLP) by leukotriene B4: evidence for cell recruitment.
Fletcher MP
J Immunol; 1986 Jun; 136(11):4213-9. PubMed ID: 3009618
[TBL] [Abstract][Full Text] [Related]
12. Effects of petrosaspongiolide M, a novel phospholipase A2 inhibitor, on acute and chronic inflammation.
Garcia-Pastor P; Randazzo A; Gomez-Paloma L; Alcaraz MJ; Paya M
J Pharmacol Exp Ther; 1999 Apr; 289(1):166-72. PubMed ID: 10087000
[TBL] [Abstract][Full Text] [Related]
13. The in vitro pharmacology of SC-51146: a potent antagonist of leukotriene B4 receptors.
Tsai BS; Keith RH; Villani-Price D; Kachur JF; Yang DC; Djuric SW; Yu S
J Pharmacol Exp Ther; 1994 Mar; 268(3):1499-505. PubMed ID: 8138960
[TBL] [Abstract][Full Text] [Related]
14. Lipopolysaccharide modulates receptors for leukotriene B4, C5a, and formyl-methionyl-leucyl-phenylalanine on rabbit polymorphonuclear leukocytes.
Goldman DW; Enkel H; Gifford LA; Chenoweth DE; Rosenbaum JT
J Immunol; 1986 Sep; 137(6):1971-6. PubMed ID: 3018083
[TBL] [Abstract][Full Text] [Related]
15. Leukocyte inhibitory factor (LIF) potentiates neutrophil responses to formyl-methionyl-leucyl-phenylalanine.
Borish L; O'Reilly D; Klempner MS; Rocklin RE
J Immunol; 1986 Sep; 137(6):1897-903. PubMed ID: 3018081
[TBL] [Abstract][Full Text] [Related]
16. Decreased polymorphonuclear leucocyte chemotactic response to leukotriene B4 in cystic fibrosis.
Lawrence RH; Sorrelli TC
Clin Exp Immunol; 1992 Aug; 89(2):321-4. PubMed ID: 1322257
[TBL] [Abstract][Full Text] [Related]
17. Lung cancer cell lines inhibit leukotriene B4 production by human polymorphonuclear leukocytes at the level of phospholipase A2.
Abe M; Matsuki H; Domae M; Kuwata H; Kudo I; Nakanishi Y; Hara N; Mitsuyama T; Furukawa T
Am J Respir Cell Mol Biol; 1996 Nov; 15(5):565-73. PubMed ID: 8918363
[TBL] [Abstract][Full Text] [Related]
18. Tumor necrosis factor-alpha priming of phospholipase A2 activation in human neutrophils. An alternative mechanism of priming.
Bauldry SA; McCall CE; Cousart SL; Bass DA
J Immunol; 1991 Feb; 146(4):1277-85. PubMed ID: 1846897
[TBL] [Abstract][Full Text] [Related]
19. Pharmacologic actions of the second-generation leukotriene B4 receptor antagonist LY293111: in vitro studies.
Jackson WT; Froelich LL; Boyd RJ; Schrementi JP; Saussy DL; Schultz RM; Sawyer JS; Sofia MJ; Herron DK; Goodson T; Snyder DW; Pechous PA; Spaethe SM; Roman CR; Fleisch JH
J Pharmacol Exp Ther; 1999 Jan; 288(1):286-94. PubMed ID: 9862783
[TBL] [Abstract][Full Text] [Related]
20. Phospholipase A2 as leukotriene B4 secretagogue for human polymorphonuclear leukocytes.
Lam BK; Yang CY; Wong PY
Adv Exp Med Biol; 1990; 275():183-91. PubMed ID: 2173367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]